News Category
Tropical Orthodontics has received the 2026 Consumer Choice Award for Business Excellence, marking its tenth straight year of recognition and undersco...
Earth Science Tech Inc. is building a scalable healthcare business through vertical integration and a dual B2B/B2C model, with plans to expand geograp...
New research shows that masked hypertension, normal office blood pressure but high at-home readings, is associated with a 70% higher risk of falls in ...
Samsung's projected $80 billion quarterly profit, driven by AI memory chip demand, highlights the sector's massive profitability and its spillover ben...
Flu infections are rising earlier than usual in the US, highlighting the need for robust diagnostic tools and timely vaccination.
Newron Pharmaceuticals has received FDA feedback on a clinical hold at U.S. sites for its Phase 3 ENIGMA-TRS 2 study and is preparing a response while...
Verbio shifts from heavy investment to optimizing new capacity and generating cash flow, marking a pivotal moment for the bioeconomy sector.
SS Innovations is positioning itself as a leader in telerobotic surgery, with 195 remote procedures performed using its SSi Mantra system and plans to...
Regentis Biomaterials is developing GelrinC, an off-the-shelf hydrogel implant that aims to regenerate hyaline-like cartilage and shift knee osteoarth...
Lantern Pharma's upcoming presentation at the ThinkEquity Conference underscores the growing investor interest in AI-powered oncology drug development...
The Trump administration's distribution of $500 checks to Healthcare.gov enrollees weeks before the midterms may offer temporary relief, but its long-...
Helus Pharma will host an investor presentation on October 21, 2026, to highlight its Phase 3 major depressive disorder candidate HLP003 and Phase 2 g...
PXG's new Torpedo ZT Putter applies Zero Torque technology to the popular Torpedo mallet design, offering golfers reduced face rotation and greater fo...
Avident Health and Unite for HER have secured a quality improvement grant from Pfizer and NCCN to deploy a digital navigation platform that bridges co...
Avatar Medical has received CE Marking for Avatar Medical Vision, the first software cleared for use with a glasses-free 3D medical display, enabling ...
Avatar Medical's CE marking for Avatar Medical Vision, the first software compatible with glasses-free 3D medical displays, enables commercialization ...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to execute a Phase 2 trial of Lucid-MS, a firs...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies (NAMs) that could accelerate clinical advancement, cut costs and ...
Nutriband Inc. has filed a non-provisional utility patent application with the USPTO for improved aversive formulations and coating methods for its AV...
SS Innovations is advancing telerobotic surgery with 195 telesurgeries and a 45% increase in installed systems, positioning itself as a key player as ...
Lantern Pharma secures Taiwan regulatory and IRB approvals to open Part 2 of its Phase 2 HARMONIC trial, potentially accelerating development of LP-30...
Quantum BioPharma's agreement with Thermo Fisher's clinical research business moves its lead multiple sclerosis drug Lucid-MS into a phase 2 trial, te...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could significantly reduce animal testing and accelerate the development of its an...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to execute a Phase 2 trial of Lucid...
XORTX Therapeutics is advancing XORLO, a proprietary oxypurinol formulation for gout, toward a New Drug Application with the FDA, potentially offering...
C60 Power's National C60 Day on October 9 honors the 1996 Nobel Prize in Chemistry for fullerenes and underscores the expanding research and consumer ...
C60 Power's National C60 Day on October 9 promotes awareness of carbon 60 research, emphasizing purity and third-party testing, while offering educati...
Quantum BioPharma's agreement with Thermo Fisher for its Phase 2 Lucid-MS trial marks a critical step toward developing a first-in-class treatment for...
Telomir Pharmaceuticals' $5.6 million PIPE financing, including a $1 million investment from John Paul DeJoria, will fund the clinical development of ...
Earth Science Tech's real estate and asset management subsidiary Avenvi LLC provides critical physical infrastructure for its pharmacy operations and ...
NanoViricides will present at the NIBA 153rd Investment Conference on Oct. 7, 2026, showcasing its broad-spectrum antiviral NV-387, which is in Phase ...
Quantum BioPharma's Study Start-Up Agreement with Thermo Fisher for its Phase 2 Lucid-MS trial signals a critical step toward developing a first-in-cl...
Gold's rebound on falling Treasury yields and weaker dollar reflects changing Fed rate expectations, with significant implications for gold miners and...
A new study reveals that the skull contains lymph node-like structures that may serve as a local immune defense for the brain, opening potential new a...
India's drug regulator has cleared Okogen's Phase 1/2 EMERALD study of Treyegen, a single therapy targeting both viral and bacterial conjunctivitis, p...
Kairos Pharma reported positive interim Phase 2 data showing ENV-105 plus apalutamide significantly improved progression-free survival in metastatic c...
AXIM Biotechnologies has submitted a 510(k) to the FDA for a next-generation lateral-flow tear lactoferrin test that could bring objective, 10-minute ...
GeoVax will present its next-generation MVA-X single-dose vaccine and continuous cell-line manufacturing platform at World Vaccine Congress Europe 202...
BFCH and NEXT10 advance a strategy to build UNLOCKD into a scalable health and wellness platform, aiming for $65-$95 million in annual revenue and up ...
The Global Markets Forum (Hybrid) on October 7-8, 2026, will feature 19 companies from around the world presenting live and virtually, offering invest...
NHS England's new rapid brain tumor test drastically reduces diagnosis time, potentially accelerating access to innovative treatments from companies l...
Oncotelic Therapeutics opens registration for its AI-powered BIO REBOOT initiative and announces two PDAOAI presentations at a major drug discovery co...
NanoViricides has provided an update on its Phase II clinical trial of NV-387 Oral Gummies for Ebola, highlighting the potential of an oral antiviral ...
HeartBeam (NASDAQ: BEAT) received FDA Breakthrough Device Designation for its HeartBeam System, a 3D ECG technology that could allow patients to asses...
A new study documenting a sharp rise in maternal cardiovascular disease and pregnancy-related complications has earned Dr. Emily S. Lau the American H...
Certified-PEP's emphasis on U.S.-made research peptides and independent batch testing through Vanguard Laboratory addresses a critical need for verifi...
Philip Ashton-Rickardt, a veteran biotech leader, argues that effective scientific leadership depends on balancing conviction with flexibility and tra...
Flushie, a family-owned pre-toilet spray brand founded in 2016, gained national recognition at the International Housewares Show, underscoring consume...
